We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Ascendis Pharma and Novo Nordisk Sign Collaboration for Development and Commercialization of TransCon Technology-based Products in Metabolic and Cardiovascular Diseases - Collaboration leverages...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 12 | 10.6194690265 | 113 | 125 | 113 | 17 | 117.42307692 | DE |
4 | 13 | 11.6071428571 | 112 | 125 | 112 | 100 | 117.54570136 | DE |
12 | 2 | 1.62601626016 | 123 | 135 | 97 | 73 | 120.0881472 | DE |
26 | 3 | 2.45901639344 | 122 | 135 | 97 | 59 | 121.27263213 | DE |
52 | -7 | -5.30303030303 | 132 | 143 | 97 | 57 | 124.1737811 | DE |
156 | -7 | -5.30303030303 | 132 | 143 | 97 | 57 | 124.1737811 | DE |
260 | -7 | -5.30303030303 | 132 | 143 | 97 | 57 | 124.1737811 | DE |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions